Search
for
Sort by
Research 151–180 of 1000+
- The clinical applications of five-alpha reductase inhibitors.
- Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance
- Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?
- Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- Post-finasteride syndrome: survey of dermatologists from the Spanish Hair and Nail Disorders Group
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- Editorial Comment
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint
- The impact of monotherapies for male androgenetic alopecia: A network meta‐analysis study
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- This Week in JAMA
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- RSPO1-mutated keratinocytes from palmoplantar keratoderma display impaired differentiation, alteration of cell–cell adhesion, EMT-like phenotype and invasiveness properties: implications for squamous cell carcinoma susceptibility in patients with 46XX disorder of sexual development
- Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Incidence and risk factors for alopecia in survivors of critical illness: A multi-centre observational study
- Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients
- Glatze in jungen Jahren könnte Risikofaktor für BPH sein
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons